A phase II study investigating cabozantinib in patients with refractory metastatic colorectal cancer (AGICC 17CRC01)

Authors

• S J. Cohen
• A Basu Mallick

Publication/Presentation Date

2-2020

Volume

38

Issue

4

Published In/Presented At

DOI: 10.1200/JCO.2020.38.4_suppl.103

Disciplines

Medicine and Health Sciences

Department(s)

Hematology-Medical Oncology Division

Document Type

Article